Boston Globe & GateHouse Settle LinkGate
Market Screener: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale: New data shows protein-based AKS-452 vaccine is shelf-stable for six months at 25° C (77° F)”
CommPro.Biz: “We Hate the Phrase “New Normal” But Here are 7 Marketing Tips for Navigating the You-Know-What” (Dec. 5, 2022)
Boston Harbor Angels: “AKS-452: The newest vaccine – COVID-19 shot developed by Beverly company reaches trial stage”
Hebrew SeniorLife: “Hebrew SeniorLife Named a Boston Globe Top Place to Work 2021:Nonprofit Senior Care Organization Ranked 24th of the Top Largest Companies”
Epoca Negocios (Brazil): “Como serão as vacinas de nova geração contra a covid-19: São inúmeros os desafios, sendo um deles a escassez de matérias-primas vitais para a fabricação dos imunizantes”
WSJ Offers Examples of Overly Complicated Corporate Descriptions
Birnbach Communications’ Top Predictions for 2011, The Top 12 Business & Technology Stories, Part IV
Twittering Interns: How do you build awareness on social media and protect your brand?
Birnbach Communications’ Top Predictions for 2011, Part III
Politico: “Brexit forces U.K. space company to expand U.S. presence”
Contract Pharma: “Akston Biosciences, Seppic Ink Commercial Supply Agreement: Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale”